Classification of thyroid hormone receptor agonists and antagonists using statistical learning approaches
暂无分享,去创建一个
[1] M. Erion,et al. Synthesis and biological evaluation of a series of liver-selective phosphonic acid thyroid hormone receptor agonists and their prodrugs. , 2008, Journal of medicinal chemistry.
[2] J. Ross Quinlan,et al. C4.5: Programs for Machine Learning , 1992 .
[3] Ifedayo Victor Ogungbe,et al. (−) Arctigenin and (+) Pinoresinol Are Antagonists of the Human Thyroid Hormone Receptor β , 2014, J. Chem. Inf. Model..
[4] Ruben Abagyan,et al. Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] Na Li,et al. Dibutyl phthalate contributes to the thyroid receptor antagonistic activity in drinking water processes. , 2010, Environmental science & technology.
[6] Peter Cornelius,et al. Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR beta subtype-selective thyromimetics. , 2003, Bioorganic & medicinal chemistry letters.
[7] Yonghua Wang,et al. Structural requirements of pyrimidine, thienopyridine and ureido thiophene carboxamide-based inhibitors of the checkpoint kinase 1: QSAR, docking, molecular dynamics analysis , 2012, Journal of Molecular Modeling.
[8] Ruili Huang,et al. Identification of Thyroid Hormone Receptor Active Compounds Using a Quantitative High-Throughput Screening Platform , 2014, Current chemical genomics and translational medicine.
[9] Wei Yang,et al. Structure-based approach for the study of thyroid hormone receptor binding affinity and subtype selectivity , 2016, Journal of biomolecular structure & dynamics.
[10] Johan Malm,et al. Thyroid receptor ligands. Part 5: novel bicyclic agonist ligands selective for the thyroid hormone receptor beta. , 2006, Bioorganic & medicinal chemistry letters.
[11] Vladimir Vapnik,et al. An overview of statistical learning theory , 1999, IEEE Trans. Neural Networks.
[12] Thomas S. Scanlan,et al. Design of thyroid hormone receptor antagonists from first principles , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[13] Steven Salzberg,et al. Programs for Machine Learning , 2004 .
[14] Yan Li,et al. In silico Prediction of Androgenic and Nonandrogenic Compounds Using Random Forest , 2009 .
[15] R. Joffe. Hormone treatment of depression , 2011, Dialogues in clinical neuroscience.
[16] Fangfang Wang,et al. Development of in silico models for pyrazoles and pyrimidine derivatives as cyclin-dependent kinase 2 inhibitors. , 2011, Journal of molecular graphics & modelling.
[17] Peter Brandt,et al. Thyroid receptor ligands. 6. A high affinity "direct antagonist" selective for the thyroid hormone receptor. , 2006, Journal of medicinal chemistry.
[18] Esa Alhoniemi,et al. Clustering of the self-organizing map , 2000, IEEE Trans. Neural Networks Learn. Syst..
[19] A. Murk,et al. T-screen to quantify functional potentiating, antagonistic and thyroid hormone-like activities of poly halogenated aromatic hydrocarbons (PHAHs). , 2006, Toxicology in vitro : an international journal published in association with BIBRA.
[20] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[21] B. Biondi,et al. Thyroid and obesity: an intriguing relationship. , 2010, The Journal of clinical endocrinology and metabolism.
[22] Mevlut Ture,et al. Using Kaplan-Meier analysis together with decision tree methods (C&RT, CHAID, QUEST, C4.5 and ID3) in determining recurrence-free survival of breast cancer patients , 2009, Expert Syst. Appl..
[23] Robert P. Sheridan,et al. Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..
[24] G. Ness,et al. Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7 alpha hydroxylase by thyroid hormone. , 1995, Archives of biochemistry and biophysics.
[25] G. Durst,et al. Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists. , 2015, Bioorganic & medicinal chemistry letters.
[26] A. Engle,et al. Synthesis and structure-activity relationships of oxamic acid and acetic acid derivatives related to L-thyronine. , 1995, Journal of medicinal chemistry.
[27] Steven L. Salzberg,et al. Book Review: C4.5: Programs for Machine Learning by J. Ross Quinlan. Morgan Kaufmann Publishers, Inc., 1993 , 1994, Machine Learning.
[28] J. Baxter,et al. Hammett analysis of selective thyroid hormone receptor modulators reveals structural and electronic requirements for hormone antagonists. , 2005, Journal of the American Chemical Society.
[29] R. Fletterick,et al. Structure-based design and synthesis of a thyroid hormone receptor (TR) antagonist. , 2002, Endocrinology.
[30] W. Singer,et al. Thyroid hormone treatment of depression. , 1995, Thyroid : official journal of the American Thyroid Association.
[31] Minsheng Zhang,et al. Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-alpha-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141. , 2007, Bioorganic & medicinal chemistry letters.
[32] Roberto Todeschini,et al. Handbook of Molecular Descriptors , 2002 .
[33] L. Ye,et al. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1. , 2003, Journal of medicinal chemistry.
[34] Johan Malm,et al. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor β subtype selective agonist KB-141 , 2008, The Journal of Steroid Biochemistry and Molecular Biology.
[35] David Ward,et al. Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data , 2003, Bioinform..
[36] Á. Pascual,et al. Thyroid hormone receptors, cell growth and differentiation. , 2013, Biochimica et biophysica acta.
[37] H. Kagechika,et al. Novel thyroid hormone receptor antagonists with an N-alkylated diphenylamine skeleton. , 2007, Bioorganic & medicinal chemistry.
[38] W. Dillmann. Editorial: thyroid hormone action and cardiac contractility - a complex affair. , 1996, Endocrinology.
[39] Katherine A. Drake,et al. Design and synthesis of complementing ligands for mutant thyroid hormone receptor TRβ(R320H): a tailor-made approach toward the treatment of resistance to thyroid hormone , 2005 .
[40] Teuvo Kohonen,et al. Self-Organizing Maps , 2010 .
[41] Hua Yu,et al. A Novel Chemometric Method for the Prediction of Human Oral Bioavailability , 2012, International journal of molecular sciences.
[42] M. D. de Gooyer,et al. Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid‐stimulating hormone receptor , 2012, British journal of pharmacology.
[43] Bernard F. Buxton,et al. Drug Design by Machine Learning: Support Vector Machines for Pharmaceutical Data Analysis , 2001, Comput. Chem..
[44] Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity. , 2007, Bioorganic & medicinal chemistry letters.
[45] Johan Malm,et al. Thyroid receptor ligands. Part 4: 4'-amido bioisosteric ligands selective for the thyroid hormone receptor beta. , 2006, Bioorganic & medicinal chemistry letters.
[46] J. Stepan,et al. Biochemical assessment of bone loss in patients on long-term thyroid hormone treatment. , 1992, Bone and Mineral.
[47] Hongmao Sun. Predicting ADMET Properties by Projecting onto Chemical Space?Benefits and Pitfalls , 2005 .
[48] Z. R. Li,et al. Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. , 2006, Journal of molecular graphics & modelling.
[49] J. Baxter,et al. A designed antagonist of the thyroid hormone receptor. , 2001, Bioorganic & medicinal chemistry letters.
[50] S. So,et al. Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia. , 2014, Journal of medicinal chemistry.
[51] J. Marugan,et al. A selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice. , 2014, Endocrinology.
[52] Johan Malm,et al. Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta. , 2004, Bioorganic & medicinal chemistry letters.
[53] R. L. Dow,et al. Thyroid receptor agonists for the treatment of androgenetic alopecia. , 2010, Bioorganic & medicinal chemistry letters.
[54] P. Ladenson,et al. Thyroid hormone antagonists: potential medical applications and structure activity relationships. , 2009, Current medicinal chemistry.
[55] H. Gronemeyer,et al. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. , 2000, Trends in pharmacological sciences.
[56] B. Rubin,et al. Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects , 2011, The Journal of Steroid Biochemistry and Molecular Biology.
[57] Vincent Laudet,et al. Principles for modulation of the nuclear receptor superfamily , 2004, Nature Reviews Drug Discovery.
[58] K. Nakao,et al. Thyroid hormone action is disrupted by bisphenol A as an antagonist. , 2002, The Journal of clinical endocrinology and metabolism.
[59] H. Gronemeyer,et al. Transcription factors 3: nuclear receptors. , 1995, Protein profile.
[60] C Helma,et al. Fragment generation and support vector machines for inducing SARs , 2002, SAR and QSAR in environmental research.
[61] S. Mandrup,et al. Molecular basis for gene-specific transactivation by nuclear receptors. , 2011, Biochimica et biophysica acta.
[62] Katherine A. Drake,et al. Design and synthesis of complementing ligands for mutant thyroid hormone receptor TRbeta(R320H): a tailor-made approach toward the treatment of resistance to thyroid hormone. , 2005, Bioorganic & medicinal chemistry.